CBUS
Cibus, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.59
+0.63%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−2.3x
Market Cap
$121.52M
MomentumView details →
1D Return
+0.63%
YTD Return
−8.33%
RSI (14)
39.8
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−2.3x
Market Cap
$121.52M
RSI (14)
39.8
MomentumView details →
1D Return
+0.63%
YTD Return
−8.33%
SummaryUpdated Jun 1, 2026
Cibus, Inc. (NASDAQ:CBUS) is a San Diego-based agricultural biotechnology company founded in 2001 that develops gene-edited plant traits for licensing to seed companies. The company went public in July 2017 and has evolved from a research-focused organization into a commercial gene editing platform. Cibus specializes in developing productivity traits that help farmers achieve higher yields while reducing chemical inputs, as well as sustainable ingredients that can replace fossil fuel-based components in various products.
Similar companies
Latest newsMore news →